Behzad Aghazadeh is venBio Select Advisor's portfolio manager. venBio returned more than 60% during the first 11 months of 2014.
| Fund Name: | VenBio Select Advisor |
| Manager | Behzad Aghazadeh |
| Portfolio Value | $7,069,981,381 |
| Change This QTR | +1.03% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | UTHR | 2,760,300 | $973,944,252 | -4% | 13.77% | ||
| 2. | ARGX | 1,238,467 | $761,657,205 | 10.77% | |||
| 3. | ASND | 5,103,055 | $702,537,582 | +3% | 9.93% | ||
| 4. | Madrigal Pharmaceuticals Inc. | 2,029,000 | $626,088,530 | 8.85% | |||
| 5. | KRYS | 2,628,822 | $411,831,255 | +1% | 5.82% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2024-04-23 | ||||
| 2024-02-14 | ||||
| 2024-02-14 | ||||
| 2024-02-14 | ||||
| 2024-02-14 |
